Nucleic Acid Extraction Kit - India CDSCO Medical Device Registration

Nucleic Acid Extraction Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000049_393ac6e9a3d79ad87744b9e5085ff95d_de11ceb30e89a07f51db0dee06d72080. This device is marketed under the brand name ProPCR. The license holder is Promea Therapeutics Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO, Zonal office, Hyderabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

Nucleic Acid Extraction Kit

UID: MFG/IVD/2022/000049_393ac6e9a3d79ad87744b9e5085ff95d_de11ceb30e89a07f51db0dee06d72080

Brand Name

ProPCR

License Holder

Promea Therapeutics Private Limited

Device Class

Class C

Approving Authority

CDSCO, Zonal office, Hyderabad

Product Information

The Nucleic Acid Extraction kit is intended to isolate nucleic acid from plasma, serum, sputum, nasal Secretions, cell free body fluids and culture Supernants.